LLY

1,066.92

+2.16%↑

JNJ

234.6

+1.69%↑

ABBV

217.33

+1.21%↑

UNH

387.88

+1.23%↑

AZN

188.38

-0.66%↓

LLY

1,066.92

+2.16%↑

JNJ

234.6

+1.69%↑

ABBV

217.33

+1.21%↑

UNH

387.88

+1.23%↑

AZN

188.38

-0.66%↓

LLY

1,066.92

+2.16%↑

JNJ

234.6

+1.69%↑

ABBV

217.33

+1.21%↑

UNH

387.88

+1.23%↑

AZN

188.38

-0.66%↓

LLY

1,066.92

+2.16%↑

JNJ

234.6

+1.69%↑

ABBV

217.33

+1.21%↑

UNH

387.88

+1.23%↑

AZN

188.38

-0.66%↓

LLY

1,066.92

+2.16%↑

JNJ

234.6

+1.69%↑

ABBV

217.33

+1.21%↑

UNH

387.88

+1.23%↑

AZN

188.38

-0.66%↓

Home・Listă Acțiuni・Xencor Inc

Xencor Inc

Deschisă

SectorSănătate

11.28 -0.27

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

11.09

Maxim

11.59

Indicatori cheie
By Trading Economics
Venit	-214M -129M
Vânzări	-24M 4.5M
EPS	-1.71
Marjă de profit	-2,854.65
Angajați	260
EBITDA	-81M -75M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+129.68% upside

Dividende
By Dow Jones
Următoarele câștiguri	4 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-170M 820M
Deschiderea anterioară	11.55
Închiderea anterioară	11.28

Sentimentul știrilor

By Acuity

34%

66%

81 / 345 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

7.87 / 10.84 Suport & Rezistență

Xencor Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

21 mai 2026, 22:48 UTC

Achiziții, Fuziuni, Preluări

Conduent to Sell Public Transit Business to Modaxo for $164 Million

21 mai 2026, 16:49 UTC

Câștiguri

Walmart's Fuel Business Benefits from Rising U.S. Gas Prices, Though Volume Per Transaction Falls -- OPIS

21 mai 2026, 16:26 UTC

Principalele dinamici ale pieței

Spotify Technology Shares Up Amid New AI Tool For Remixing Songs

21 mai 2026, 23:51 UTC

Market Talk

Nikkei Might Rise on Continued Hopes for Possible U.S.-Iran Deal -- Market Talk

21 mai 2026, 23:37 UTC

Câștiguri

Lenovo Group 4Q Oper Profit $886.0M Vs. $331.0M >0992.HK

21 mai 2026, 23:37 UTC

Câștiguri

Lenovo Group 4Q Rev $21.60B Vs. $16.98B >0992.HK

21 mai 2026, 23:37 UTC

Câștiguri

Lenovo Group 4Q Net $521.0M Vs. Net $90.0M >0992.HK

21 mai 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Mixed Sentiment -- Market Talk

21 mai 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

21 mai 2026, 23:30 UTC

Market Talk

Napier Port Loses Bull Despite Robust 1H Result -- Market Talk

21 mai 2026, 22:33 UTC

Achiziții, Fuziuni, Preluări

Conduent to Sell Public Transit Business to Modaxo for $164M

21 mai 2026, 21:53 UTC

Câștiguri

Marvell Stock Notches Its 15th Record Closing High This Year -- Barrons.com

21 mai 2026, 21:02 UTC

Câștiguri

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, Nebius, Bloom Energy, Applied Digital, Intuit, D-Wave, Spotify, and More -- Barrons.com

21 mai 2026, 20:55 UTC

Câștiguri

Walmart Sales Rise as It Navigates Higher Fuel Prices -- 2nd Update

21 mai 2026, 20:30 UTC

Acțiuni populare

Stocks to Watch Recap: Nvidia, Spotify, Stellantis, Intuit -- WSJ

21 mai 2026, 20:20 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 mai 2026, 20:20 UTC

Market Talk

Mexico's Revised 1Q GDP Seen Confirming Contraction -- Market Talk

21 mai 2026, 20:20 UTC

Câștiguri

Webull 1Q Adj EPS 3c >BULL

21 mai 2026, 20:20 UTC

Câștiguri

Webull 1Q Rev $159.9M >BULL

21 mai 2026, 20:18 UTC

Market Talk

Mexico's Inflation Seen Easing in Early May -- Market Talk

21 mai 2026, 20:18 UTC

Câștiguri

Webull 1Q Loss/Shr 4c

21 mai 2026, 19:43 UTC

Market Talk

Oil Futures Lose Ground on Hopes for U.S.-Iran Deal -- Market Talk

21 mai 2026, 19:33 UTC

Market Talk

U.S. Natural Gas Futures Edge Up in Steady Trading -- Market Talk

21 mai 2026, 18:58 UTC

Câștiguri

Nvidia Is Now the Megacap Cash Machine, and Big Tech Is Footing the Bill -- Barrons.com

21 mai 2026, 18:15 UTC

Market Talk

Gold Higher For Second Consecutive Day -- Market Talk

21 mai 2026, 17:40 UTC

Market Talk

Prolonged War Putting Energy Normalcy Further Away -- Market Talk

21 mai 2026, 17:04 UTC

Market Talk

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 mai 2026, 17:01 UTC

Câștiguri

These Stocks Are Today's Movers: Nvidia, IBM, Rigetti, GlobalFoundries, Nebius, Applied Digital, Intuit, Spotify, and More -- Barrons.com

21 mai 2026, 16:20 UTC

Market Talk

Câștiguri

Stellantis Targets Distant but Constructive -- Market Talk

21 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Comparație

Modificare preț

Xencor Inc Așteptări

Obiectiv de preț

By TipRanks

129.68% sus

Prognoză pe 12 luni

Medie 26 USD 129.68%

Maxim 43 USD

Minim 13 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruXencor Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 12 analiști care au acordat evaluări ale acțiunilor Xencor Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

7.87 / 10.84Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

81 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design XmAb technologies and develop candidates with properties. Its antibody design is focused on the segment of antibodies that interact with target antigens. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Vibecotamab, Tidutamab, XmAb841, XmAb104, XmAb306, XmAb104, XmAb564 and XmAb698.